Drug survival in rheumatoid arthritis-Reference-Cited by-同舟云学术

Drug survival in rheumatoid arthritis

Published:2006-07-22 Issue:9 Volume:45 Page:1178-1178
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Mulherin D.,Wong M.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/45/9/1178/18097603/kel245.pdf

Reference5 articles.

1. ‘Compliance’ is futile but is ‘concordance’ between rheumatology patients and health professionals attainable?;Treharne;Rheumatology,2006

2. The epidemiology of drug treatment failure in rheumatic arthritis. Bailliére's Clin Rheumatol:;Wolfe;Int Pract Res,1995

3. The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs;Wong;Rheumatology,2005

4. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication;Horne;Psychol Health,1999

5. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI);Marteau;Br J Clin Psy,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years;Rheumatology Advances in Practice;2024-01-01

2. Effectiveness, safety and economic analysis of Benepali in clinical practice;Reumatología Clínica (English Edition);2021-12

3. Efectividad, seguridad y análisis económico de Benepali en práctica clínica;Reumatología Clínica;2021-12

4. Measures of Anxiety in Rheumatic Diseases;Arthritis Care & Research;2020-10

5. Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011;Wiener klinische Wochenschrift;2018-02-14